Dr. Esmée Lauren Looman is a resident in Radiation Oncology at University Hospital Zurich, Switzerland, and is currently working for one year at the Center for Proton Therapy Paul Scherrer Institute in Switzerland as part of her residency program.

Dr Looman is active in clinical research with a specialization in head and neck oncology. As part of the residency program at University Hospital Zurich, she participated in the Clinical Scientist Program, which allowed for one year full time research. Her clinical research interests are mainly focused on lymphatic spread patterns in head and neck cancer and the potential for personalization and de-escalation of the elective nodal irradiation. Currently, a phase II trial is running in Switzerland on personalized de-escalation of the elective clinical target volume (CTV) in patients diagnosed with oropharyngeal squamous cell carcinoma (DeEscO trial, Clinicaltrials.gov NCT06563362). Her other research projects focus on the safety and adverse events of combining stereotactic body radiotherapy (SBRT) with biological cancer therapies (BCT), such as immunotherapy, molecular antibodies and small molecules.

She is also an active member of ESTRO, EORTC Head and Neck group, and the Swiss Cancer Institute Head and Neck group.